HBIO
Harvard Bioscience Inc
$6.63
+0.28 (+4.41%)
At close · Jul 7
Market Cap
$29.90M
Shares
4,510,182
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-02 | — | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-21 | 2026-06-02 | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-13 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-03-10 | 2026-03-06 | |
| 8-K | 2026-03-06 | — | |
| 8-K | 2026-02-10 | — | |
| DEF 14A | 2026-01-30 | 2026-03-06 | |
| 8-K | 2026-01-29 | 2026-01-23 | |
| 8-K | 2026-01-20 | 2026-01-19 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-17 | — | |
| 8-K | 2025-12-05 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-03 | 2025-10-02 | |
| 8-K | 2025-09-09 | 2025-09-05 | |
| 8-K | 2025-08-13 | 2025-08-12 | |
| 8-K | 2025-08-11 | 2025-08-08 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-07-17 | 2025-07-16 | |
| 8-K/A | 2025-06-27 | 2025-06-18 | |
| 8-K | 2025-06-23 | 2025-06-18 | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 8-K | 2025-06-02 | 2025-05-30 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-21 | 2025-06-02 | |
| 8-K | 2025-04-16 | 2025-04-10 | |
| 8-K | 2025-04-10 | — | |
| 10-K | 2025-03-14 | 2024-12-31 | |
| 8-K | 2025-03-12 | 2025-03-10 | |
| 8-K | 2025-03-12 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-03 | 2024-05-14 | |
| 8-K | 2024-04-03 | 2024-03-28 | |
| 8-K | 2024-03-26 | 2024-03-21 | |
| 10-K | 2024-03-07 | 2023-12-31 | |
| 8-K | 2024-03-07 | — |
Showing 1–50 of 111 filings